DePrimo, S. E., Huang, X., Blackstein, M. E., Garrett, C. R., Harmon, C. S., Schöffski, P., . . . Demetri, G. D. (2009). Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure.
Chicago-tyylinen lähdeviittausDePrimo, Samuel E., et al. Circulating Levels of Soluble KIT Serve As a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib Following Imatinib Failure. 2009.
MLA-viiteDePrimo, Samuel E., et al. Circulating Levels of Soluble KIT Serve As a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib Following Imatinib Failure. 2009.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.